Related Experiment Videos
Vanidil: a newly synthesized antiangina nonvolatile organic solid nitrate
1Department of Pharmacology, Kaohsiung Medical College, Taiwan, Republic of China.
Gaoxiong Yi Xue Ke Xue Za Zhi = the Kaohsiung Journal of Medical Sciences
|September 1, 1991
Summary
Newly synthesized Vanidil, a novel organic nitrate, effectively inhibits coronary vasocontraction in vitro. This compound shows promise as a potential antiangina agent for treating vasospastic conditions.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Organic Chemistry
Background:
- Coronary vasospasm is a significant cause of angina.
- 3,4-diaminopyridine induces coronary vasocontraction in vitro.
- Novel vasodilatory agents are needed for antiangina therapy.
Purpose of the Study:
- To synthesize and characterize a new organic nitrate compound, Vanidil.
- To evaluate the in vitro efficacy of Vanidil in inhibiting coronary vasocontraction.
- To assess the potential of Vanidil as an antiangina agent.
Main Methods:
- Chemical synthesis of Vanidil (4-o-(1,2-dinitroglyceryl)-6-nitrovanillic acid).
- In vitro testing using pig coronary artery preparations.
- Assessment of Vanidil's inhibitory effects on 3,4-diaminopyridine-induced vasocontraction.
Main Results:
- Vanidil was successfully synthesized as a nonvolatile organic solid nitrate.
- Vanidil demonstrated inhibition of rhythmic vasocontraction induced by 3,4-diaminopyridine.
- Vanidil also inhibited nonrhythmic tonic vasocontraction in the tested models.
Conclusions:
- Vanidil exhibits potent in vitro vasodilatory properties.
- The novel compound Vanidil is a potential therapeutic candidate for managing coronary vasospasm.
- Further research is warranted to explore Vanidil's antiangina potential in vivo.